TraQiQ signs partnership with Roha housing finance for Nationwide delivery and distribution.
Bellevue WA, Nov. 29, 2021 (GLOBE NEWSWIRE) -- TraQiQ, Inc. (OTC QB: TRIQ) (the "Company" or "TraQiQ"), a leading provider of Last mile & Fintech solutions announced today that Roha Housing Finance will be deploying TraQiQ’s distribution software, TraQSuite, to provide easy access of their services to customers across India.
Roha housing finance is a fast-growing member of the JJT group and focuses on providing home loans to consumers. Roha focuses on making the home loan process easy and transparent for their customers. As part of that goal, they are focused on minimizing legacy processes and paperwork that plague this industry.
TraQiQ’s Software Solution, TraQSuite, will help Roha manage its network of people. TraQSuite will also track and manage agent activity during the entire product lifecycle. This includes scheduling meetings, providing advance notice of agent arrival, feedback on agent interaction and back-office functions like report generation.
TraQSuite will also enable Roha’s customers with simple and rapid access to their products. Roha will be leveraging TraQSuite to automate their loan disbursal processes where loan documents can be easily verified, stored, and retrieved for a seamless experience for both customer and company.
“The TraQiQ team is excited to be able to offer this new service for Roha Housing Finance” said Lathika Regunathan, President of TraQiQ Solutions. “In a market like India, it is critical for companies to become sensitive to customer requirements. Removing red-tape and increasing transparency makes companies more attractive to their customers. This is where we believe TraQSuite can be very useful for Roha.”
About TraQiQ, Inc.
TraQiQ, Inc. is a global technology company with a suite of products designed to help identify customers, facilitate transactions, and fulfill transactions. TraQiQ’s leading edge FinTech and AI solutions have been deployed with leading multi-national customers around the world and are helping increase customer loyalty, improving profitability and driving efficient financial transactions.
Connect on social media at:
https://www.facebook.com/TraQiQ
https://twitter.com/TraQiQ
https://www.linkedin.com/company/TraQiQ
For more information, please visit www.TraQiQ.com
The company posts updates through videos from the official company’s YouTube channel
https://www.youtube.com/channel/UCxGjqDd7jwB-0qo1_o3isrw
Please join the conversation on our TraQiQ supporter’s telegram group at https://t.me/traqiq
Cautionary Note Regarding Forward-Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements reflect the Company's expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. The potential risks and uncertainties include, among others, the risks listed in the company’s most recent annual report on Form 10-K and other documents filed by the company with the Securities and Exchange Commission. These statements are based upon the current beliefs and expectations of the Company's management and are subject to significant risks and uncertainties, including those detailed in the Company's filings with the Securities and Exchange Commission. Actual results, performance, prospects, and opportunities to may differ materially from those set forth in, or implied by, the forward-looking statements.
For inquiries:
TraQiQ, Inc.
Tel: +1 425-818-0560
Email: ir@TraQiQ.com
SOURCE TraQiQ, Inc.
© 2021 GlobeNewswire, Inc. All Rights Reserved.
NRx Pharmaceuticals (Nasdaq: NRXP): FDA Declines Emergency Use Authorization for ZYESAMI (aviptadil) for subgroup of Patients with Critical COVID-19 at immediate risk of death from respiratory failure despite treatment with approved therapy, including remdesivir
